Ryman Healthcare Limited
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a RYHTY research report →
Price Chart
About the company
Founded in 1984 and headquartered in Christchurch, New Zealand, Ryman Healthcare Limited is a company dedicated to the development, ownership, and operation of comprehensive retirement communities, rest homes, and hospitals designed for the elderly throughout New Zealand and Australia. These integrated villages offer a diverse range of living options, from independent townhouses and apartments to serviced apartments, alongside dedicated care facilities. The care centers provide various support services, including residential aged care, hospital-level care, specialized dementia care, and both respite and day care.
- CEO
- Naomi James
- IPO
- 2013
- Employees
- 7,800
- HQ
- Christchurch, CAN, NZ
Get TickerSpark's AI analysis on RYHTY
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $1.24B
- P/E
- -12.89
- PEG
- -0.48
- P/S
- 2.70
- P/B
- 0.53
- EV/EBITDA
- 73.98
- Div Yield
- 0.00%
- Gross Margin
- -2.22%
- Op Margin
- -2.22%
- Net Margin
- -21.46%
- ROE
- -4.17%
- ROIC
- -0.14%
Latest fiscal year · YoY change
- Revenue
- $824.34M+15.5%
- Gross Profit
- $-18,337,241-102.6%
- Op Income
- $-18,337,241
- Net Income
- $-176,894,209+59.5%
- EPS
- $-0.90+70.5%
- OCF Growth
- -19.6%
- FCF Growth
- -7.2%
- 52W High
- $8.61
- 52W Low
- $6.11
- 50D MA
- $6.11
- 200D MA
- $7.00
- Beta
- 0.34
- RSI (14)
- 1
- Avg Volume
- 76
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Ryman said FY26 was an operational inflection point, with doubled operating EBITDAF, positive free cash flow of $188 million, and a stronger balance sheet as the business shifts toward more recurring care earnings.· May 25, 2026
- Operating EBITDAF doubled and free cash flow turned positive at $188 million for the first time in more than a decade.
- Operating revenue increased 10%, supported by fee growth in aged care and retirement living and a 2.6% rise in residents.
- Gross annualized cost savings reached $57 million since FY24, at the top end of the $50 million to $60 million guidance range.
- Net debt fell $94 million to $1.57 billion; the refinance left no bank maturities until FY31 and average debt cost at 5.9%.
- Management flagged FY27 as a year to reduce vacant stock, lift resales toward turnover, and keep growing care occupancy and earnings.
FY26 operating revenue increased 10%, driven by fee growth across aged care and retirement living plus a 2.6% increase in residents. Management said operating EBITDAF doubled, and free cash flow was $188 million, the first positive free cash flow in more than a decade. Gross annualized cost savings totaled $57 million since FY24, and FY26 capex was $222 million, slightly below the $235 million guidance. Net debt finished at $1.57 billion, down $94 million year over year, while the average cost of debt was 5.9% after refinancing. For care, second-half EBITDAF per bed was $20,200; revenue per bed rose 6% in New Zealand and 9% in Australia; care cash flow was $81 million; and revenue in care grew 7% in the second half versus 3% expense growth. For FY27, management said retirement living will focus on reducing vacant stock and lifting resales to match turnover by year-end, care performance should keep building, and build rate and capex will be lower due to a more disciplined development approach.
Naomi James framed FY26 as an inflection point, saying the last two years of work are now showing up in better performance, cash generation, and balance sheet strength. She emphasized that Ryman is becoming more care-centric, with only two sites under construction, a higher-quality portfolio, and more flexibility through the cycle. Her tone was confident but measured: she highlighted demand in care, acknowledged uncertainty in retirement living and property markets, and repeatedly pointed to FY27 as a year of execution rather than expansion.
Matthew Prior focused on margin recovery, cash conversion, and balance-sheet repair. He cited operating revenue up 10%, EBITDAF doubling, NZ EBITDAF margins expanding 250 basis points, $57 million of gross annualized cost savings since FY24, and free cash flow up more than $280 million year over year. He also noted net debt of $1.57 billion, industry-low gearing below 28%, $675 million of debt headroom, annualized gross interest costs down $68 million since February 2025, and an average cost of debt of 5.9% after the refinancing.
Analysts pressed on resale margins, divestment timing, capital allocation, land buying, and whether sales momentum is easing. Management said resale margins are moderating but at a slowing rate, with independent resale margin still at 27% and mix toward service apartments weighing on the average. On capital management, Naomi said the board is working within a 20% to 30% gearing framework and is considering reinvestment, debt reduction, dividends, and buybacks depending on what best supports shareholder value. Management also said it is not prioritizing new land purchases right now, is focused on existing assets and selected divestments, and sees more growth opportunity in care occupancy and service-apartment product changes than in independent sales.
The call showed that operational changes are starting to convert into cash: earnings doubled, free cash flow was positive, costs came out, and debt was refinanced on better terms. Management also pointed to sustained care demand, rising occupancy, higher premiums/RADs, and a new Resident Fund product that already retained $17 million of capital in FY26.
Retirement living remains exposed to subdued and competitive housing markets, with resale margins still moderating and sales momentum uneven by region. Management also flagged uncertainty from global events, possible fuel surcharges and cost inflation, and acknowledged that New Zealand care profitability still depends heavily on future funding reform and better occupancy growth.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 99.9%
- Shares Outstanding
- 202.97M
- Float Shares
- 202.73M
Our RYHTY coverage
Recent articles, reports, and earnings notes.
No research on RYHTY yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate RYHTY report →Critical Survey: Ryman Healthcare (OTCMKTS:RYHTY) vs. LifeMD (NASDAQ:LFMD)
defenseworld.net · Jul 30
Ryman Healthcare Limited (RYHTY) Shareholder/Analyst Call Transcript
seekingalpha.com · Jul 28
Ryman Healthcare Limited (RYHTY) Analyst/Investor Day Transcript
seekingalpha.com · Feb 9
Reviewing Ryman Healthcare (OTCMKTS:RYHTY) and CVS Health (NYSE:CVS)
defenseworld.net · Jan 31
Critical Contrast: Ryman Healthcare (OTCMKTS:RYHTY) and Enhabit (NYSE:EHAB)
defenseworld.net · Dec 27
Ryman Healthcare Limited (RYHTY) Q2 2026 Earnings Call Transcript
seekingalpha.com · Nov 26
Ryman Healthcare Limited (RYHTY) Q4 2025 Earnings Call Transcript
seekingalpha.com · May 29
Ryman Healthcare Limited (RYHTY) Q2 2025 Earnings Call Transcript
seekingalpha.com · Nov 27
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.